BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1173683)

  • 1. [Changes in alveolar surfactant in alloxan diabetes].
    Garbagni R; Cardellino G; Dalmasso F; Stratta Monga P
    Minerva Med; 1975 Jun; 66(43):2094-7. PubMed ID: 1173683
    [No Abstract]   [Full Text] [Related]  

  • 2. [Alveolar surfactant and experimental diabetes (protective action of citicoline)].
    Iozzo A; Cardellino G; Dalmasso F; Garbagni R
    Arch Sci Med (Torino); 1978; 135(2):181-6. PubMed ID: 581158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Action of heparin on pulmonary lipids and alveolar surfactant in rabbits].
    Iozzo A; Garbagni R; Dalmasso F; Cardellino G; Giacone A; Pellegrino S; Tondolo M
    Minerva Med; 1980 Apr; 71(13):953-7. PubMed ID: 6892843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surfactant system of lung in rats with different resistance to stress under alloxan diabetes].
    Vasiljeva NN; Bryndina IG; Protasova SV; Butolin EG
    Patol Fiziol Eksp Ter; 2014; (1):44-7. PubMed ID: 25051683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipids in the lungs and alveolar surfactant in anaphylactic shock].
    Bashmakov IuK; Briuzgina TS
    Fiziol Zh (1978); 1990; 36(1):87-90. PubMed ID: 2323452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of desipramine treatment on pulmonary phospholipid metabolism in rats.
    Yano T; Kitagawa H
    Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):353-63. PubMed ID: 2385758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular dynamics and lipid metabolism in the lung.
    Naimark A
    Fed Proc; 1973 Sep; 32(9):1967-71. PubMed ID: 4740780
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in lipids of the lung induced by alloxan diabetes and insulin hypoglycemia].
    Stratta Monga P; Grassini G; Piacentino R; Garbagni R; Cardellino G
    Minerva Med; 1973 Nov; 64(83):4411-7. PubMed ID: 4771466
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental diabetes and the lung. I. Changes in growth, morphometry, and biochemistry.
    Ofulue AF; Kida K; Thurlbeck WM
    Am Rev Respir Dis; 1988 Jan; 137(1):162-6. PubMed ID: 3337458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Labeling of phospholipids in the surfactant and subcellular fractions of rabbit lung.
    Jobe A; Kirkpatrick E; Gluck L
    J Biol Chem; 1978 Jun; 253(11):3810-6. PubMed ID: 580614
    [No Abstract]   [Full Text] [Related]  

  • 11. Lung lipid metabolism, mechanisms of its regulation and alveolar surfactant.
    van Golde LM
    Bull Eur Physiopathol Respir; 1979; 15(6):65p-84p. PubMed ID: 583604
    [No Abstract]   [Full Text] [Related]  

  • 12. [Function, composition, biosynthesis and degradation of the surfactant system (anti-atelectasis factor) of the lung].
    Winsel K; Iwainsky H
    Pharmazie; 1980; 35(10):575-81. PubMed ID: 7005910
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in lung morphologic features and elasticity caused by streptozotocin-induced diabetes mellitus in growing rats.
    Kida K; Utsuyama M; Takizawa T; Thurlbeck WM
    Am Rev Respir Dis; 1983 Jul; 128(1):125-31. PubMed ID: 6688163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of parenteral nutrition on lung surfactant in the traumatized rat.
    Bahrami S; Gasser H; Strohmaier W; Redl H; Schlag G
    Prog Clin Biol Res; 1987; 236B():295-303. PubMed ID: 3112798
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypobaric hypoxia on pulmonary wash fluid of rats.
    Prévost MC; Vieu C; Douste-Blazy L
    Respiration; 1980; 40(2):76-80. PubMed ID: 6893755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the alveolar surfactant in Mendelson's syndrome. Introductory note to the description of a clinical case].
    Azzollini CV; Ravera R; Berghella S; Grosso E
    Minerva Anestesiol; 1978 Jun; 44(6):433-40. PubMed ID: 581698
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fatty acid composition and content of individual lipid fractions in adipose and muscle tissue of albino rats with alloxan diabetes].
    Martikian AR; Vartanian GS; Karagezian KG
    Biull Eksp Biol Med; 1984 Jul; 98(7):33-5. PubMed ID: 6466824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo clearance of natural and modified surfactant.
    Pettenazzo A; Jobe A; Ikegami M; Rubaltelli FF
    Eur Respir J Suppl; 1989 Mar; 3():13s-15s. PubMed ID: 2742682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regulation of free radical oxidation of pulmonary surfactant lipids].
    Verbolovich VP; Petrenko EP; Podgornyĭ IuK
    Vopr Med Khim; 1985; 31(5):65-8. PubMed ID: 3841433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary alveolar proteinosis.
    McClenahan JB
    Arch Intern Med; 1974 Feb; 133(2):284-7. PubMed ID: 4405909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.